WuXi AppTec closes RMB2.3bn IPO on Shanghai Stock Exchange
Executive Summary
WuXi AppTec Inc. (contract drug discovery and cGMP manufacturing services) grossed RMB21.60 ($354mm) in an initial public offering of 104mm shares at RMB21.60 on the Shanghai Stock Exchange.
Deal Industry
- Biotechnology
- Contract Research Organization-CRO
- Medical Devices
- Pharmaceuticals
- Services
Deal Status
- Final
Deal Type
-
Financing
- IPO
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice